Researchers are uncovering how disrupted glutamatergic synapses drive diverse forms of intellectual disability, revealing new ...
Researchers at Leipzig University and TU Dresden have succeeded in developing biological switches that can selectively turn ion channels on and off using light pulses. Initial applications show that ...
The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, Jan. 6, 2026 /PRNewswire/ -- HUYABIO International today announced favorable Phase 1 clinical data for ...
A new materials study from Japan shows that targeted scandium substitution in layered sodium manganese oxide can mitigate the lattice strain responsible for rapid capacity fade in sodium-ion battery ...
CATL is already dominating the global electric vehicle battery market, but now the company is saying sodium-ion batteries will be widely available by the end of 2026. When is CATL launching sodium-ion ...
QurAlis intends to advance QRL-101 into Phase 2 proof-of-concept clinical trials as a potentially best-in-class treatment for both DEE and ALS CAMBRIDGE, Mass., December 29, 2025--(BUSINESS ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--QurAlis Corporation (“QurAlis”), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to ...
The heterogeneous nature of the mechanisms underlying neuropathic pain complicates the selection of appropriate treatments for individual patients. Although systematic reviews have outlined the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results